Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population

被引:69
作者
Yamada, Chizumi [1 ]
Mitsuhashi, Toshitake [1 ]
Hiratsuka, Noboru [1 ]
Inabe, Fumiyo [1 ]
Araida, Nami [1 ]
Takahashi, Eiko [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Tokyo 151, Japan
关键词
Homeostasis model assessment of insulin resistance; Reference interval; C28-A3; TYPE-2; DIABETIC-PATIENTS; BODY-MASS INDEX; NONOBESE; SENSITIVITY; PREVALENCE; GLUCOSE;
D O I
10.1111/j.2040-1124.2011.00113.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to establish a reference interval for homeostasis model assessment of insulin resistance (HOMA-IR) in a Japanese population based on the C28-A3 document from the Clinical and Laboratory Standards Institute (CLSI). We selected healthy subjects aged 20-79 years, with fasting plasma glucose < 100 mg/dL, body mass index < 25 kg/m(2) and alanine aminotransferase < 31 U/L. HOMA-IR values were log transformed, values beyond mean +/- 3 standard deviations (SD) were truncated, and the mean +/- 2 SD of log HOMA-IR values were taken as the upper and lower reference limits of HOMA-IR. We selected 2173 subjects as reference individuals, and 2153 subjects were used for analysis. The reference interval for HOMA-IR was established as between 0.4 and 2.4. This represents the first reference interval study for HOMA-IR that applies the stringent CLSI C28-A3 document. HOMA-IR >= 2.5 should be considered a reasonable indicator of insulin resistance in Japanese. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00113.x, 2011)
引用
收藏
页码:373 / 376
页数:4
相关论文
共 19 条
[1]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[2]  
[Anonymous], 1995, PHYS STATUS USE INTE
[3]  
[Anonymous], 2008, DEFINING ESTABLISHIN
[4]   Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population [J].
Ascaso, JF ;
Romero, P ;
Real, JT ;
Priego, A ;
Valdecabres, C ;
Carmena, R .
MEDICINA CLINICA, 2001, 117 (14) :530-533
[5]   Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [J].
Barba, C ;
Cavalli-Sforza, T ;
Cutter, J ;
Darnton-Hill, I ;
Deurenberg, P ;
Deurenberg-Yap, M ;
Gill, T ;
James, P ;
Ko, G ;
Miu, AH ;
Kosulwat, V ;
Kumanyika, S ;
Kurpad, A ;
Mascie-Taylor, N ;
Moon, HK ;
Nishida, C ;
Noor, MI ;
Reddy, KS ;
Rush, E ;
Schultz, JT ;
Seidell, J ;
Stevens, J ;
Swinburn, B ;
Tan, K ;
Weisell, R ;
Wu, ZS ;
Yajnik, CS ;
Yoshiike, N ;
Zimmet, P .
LANCET, 2004, 363 (9403) :157-163
[6]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[7]   Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea [J].
Chang, SA ;
Kim, HS ;
Yoon, KH ;
Ko, SH ;
Kwon, HS ;
Kim, SR ;
Lee, WC ;
Yoo, SJ ;
Son, HS ;
Cha, BY ;
Lee, KW ;
Son, HY ;
Kang, SK .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (02) :142-146
[8]   The metabolic syndrome [J].
Eckel, Robert H. ;
Alberti, K. G. M. M. ;
Grundy, Scott M. ;
Zimmet, Paul Z. .
LANCET, 2010, 375 (9710) :181-183
[9]  
Japan Diabetes Society, 2010, TREATM GUID DIAB 201
[10]   Prevalence and determinants of insulin resistance among US adolescents - A population-based study [J].
Lee, Joyce M. ;
Okumura, Megumi J. ;
Davis, Matthew M. ;
Herman, William H. ;
Gurney, James G. .
DIABETES CARE, 2006, 29 (11) :2427-2432